{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:50:15Z","timestamp":1773013815427,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.clinthera.2007.06.020","type":"journal-article","created":{"date-parts":[[2007,8,9]],"date-time":"2007-08-09T11:38:50Z","timestamp":1186659530000},"page":"1184-1202","source":"Crossref","is-referenced-by-count":19,"title":["Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: A European model based on the CLARITY and COMMIT trials"],"prefix":"10.1016","volume":"29","author":[{"given":"Jenny","family":"Berg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Spiesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Parry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2007.06.020_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation [published corrections appear in N Engl J Med. 2001;345:1506 and 1716]","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2007.06.020_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2007.06.020_bib3","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial [published correction appears in JAMA. 2003;289:987]","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2007.06.020_bib4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2007.06.020_bib5","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2007.06.020_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2796.2004.01324.x","article-title":"Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: A long-term model based on the CURE trial","volume":"255","author":"Lindgren","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2007.06.020_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clinthera.2005.01.008","article-title":"The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden","volume":"27","author":"Lindgren","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2007.06.020_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s10198-005-0323-0","article-title":"The cost-effectiveness of dual oral antiplatelet therapy following percutaneous coronary intervention: A Swedish analysis of the CREDO trial","volume":"6","author":"Ringborg","year":"2005","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.clinthera.2007.06.020_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0272989X9701700202","article-title":"Primer on medical decision analysis: Part 2-building a tree","volume":"17","author":"Detsky","year":"1997","journal-title":"Med Decis Making"},{"key":"10.1016\/j.clinthera.2007.06.020_bib10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: A practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med Decis Making"},{"key":"10.1016\/j.clinthera.2007.06.020_bib11","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1161\/01.CIR.98.18.1860","article-title":"Acute coronary syndromes in the GUSTO-IIb trial: Prognostic insights and impact of recurrent ischemia","volume":"98","author":"Armstrong","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2007.06.020_bib12","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/01.CIR.0000036598.12888.DE","article-title":"Scores for post-myocardial infarction risk stratification in the community","volume":"106","author":"Singh","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2007.06.020_bib13","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000051362.96946.15","article-title":"Early and late effects of clopidogrel in patients with acute coronary syndromes","volume":"107","author":"Yusuf","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2007.06.020_bib14","series-title":"Hospital Discharge Register and Cause of Death Register","author":"Swedish National Board of Health and Welfare","year":"2003"},{"key":"10.1016\/j.clinthera.2007.06.020_bib15","series-title":"Inter national Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)","author":"US Dept of Health and Human Services","year":"2003"},{"key":"10.1016\/j.clinthera.2007.06.020_bib16","article-title":"International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10)","author":"World Health Organization (WHO)","year":"2004"},{"key":"10.1016\/j.clinthera.2007.06.020_bib17","series-title":"Studies in Health Economics: Modelling and Data Analysis of Costs and Survival","article-title":"Consumption and production by age in Sweden: Basic facts and health economic implications [dissertation]","author":"Ekman","year":"2002"},{"key":"10.1016\/j.clinthera.2007.06.020_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-8510(00)00111-1","article-title":"Health-related quality of life by disease and socio-economic group in the general population in Sweden","volume":"55","author":"Burstrom","year":"2001","journal-title":"Health Policy"},{"key":"10.1016\/j.clinthera.2007.06.020_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2796.1999.00546.x","article-title":"Costs of coronary heart disease and stroke: The case of Sweden","volume":"246","author":"Zethraeus","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2007.06.020_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2165\/00019053-200321090-00003","article-title":"The comparative medical costs of atherothrombotic disease in European countries","volume":"21","author":"Levy","year":"2003","journal-title":"Pharmaco Economics"},{"key":"10.1016\/j.clinthera.2007.06.020_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s10389-005-0112-3","article-title":"Cost of atherothrombotic diseases\u2014myocardial infarction, ischaemic stroke and peripheral arterial occlusive disease\u2014in Germany","volume":"13","author":"Bruggenjurgen","year":"2005","journal-title":"J Public Health"},{"key":"10.1016\/j.clinthera.2007.06.020_bib23","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1468-1331.2005.01091.x","article-title":"Medical resource use and costs of health care after acute stroke in Germany","volume":"12","author":"Rossnagel","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinthera.2007.06.020_bib24","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.STR.0000217450.21310.90","article-title":"Lifetime cost of ischemic stroke in Germany: Results and national projections from a population-based stroke registry: The Erlangen Stroke Project","volume":"37","author":"Kolominsky-Rabas","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2007.06.020_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000075782","article-title":"Costs of stroke care according to handicap levels and stroke subtypes","volume":"17","author":"Spieler","year":"2004","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.clinthera.2007.06.020_bib26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1053\/euhj.2000.2484","article-title":"At what coronary risk level is it cost-effective to initiate cholesterol lowering drug treatment in primary prevention?","volume":"22","author":"Johannesson","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2007.06.020_bib28","series-title":"Main Economic Indicators: Consumer Prices","year":"2006"},{"key":"10.1016\/j.clinthera.2007.06.020_bib30","series-title":"Euro\/ECU exchange rates","author":"Eurostat","year":"2006"},{"key":"10.1016\/j.clinthera.2007.06.020_bib31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2165\/00019053-199507030-00008","article-title":"The cost effectiveness of hypertension treatment in Sweden","volume":"7","author":"Johannesson","year":"1995","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.clinthera.2007.06.020_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0167-6296(96)00507-3","article-title":"Accounting for future costs in medical cost-effectiveness analysis","volume":"16","author":"Meltzer","year":"1997","journal-title":"J Health Econ"},{"key":"10.1016\/j.clinthera.2007.06.020_bib33","series-title":"The Human Mortality Database","author":"University of California, Berkeley (USA)","year":"2003"},{"key":"10.1016\/j.clinthera.2007.06.020_bib34","series-title":"General guidelines for economic evaluations from the Pharmaceutical Benefits Board","year":"2003"},{"key":"10.1016\/j.clinthera.2007.06.020_bib35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V","article-title":"Definition, interpretation and calculation of cost-effectiveness acceptability curves","volume":"9","author":"Lothgren","year":"2000","journal-title":"Health Econ"},{"key":"10.1016\/j.clinthera.2007.06.020_bib36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1524-4733.2004.75003.x","article-title":"Use of cost-effectiveness analysis in health-care resource allocation decision-making: How are cost-effectiveness thresholds expected to emerge?","volume":"7","author":"Eichler","year":"2004","journal-title":"Value Health"},{"key":"10.1016\/j.clinthera.2007.06.020_bib37","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jech.51.6.636","article-title":"Low levels of cardiovascular risk factors and coronary heart disease in a UK Chinese population","volume":"51","author":"Harland","year":"1997","journal-title":"J Epidemiol Community Health"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2007.06.020_bib38","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0167-5273(97)00211-8","article-title":"New risk factors for coronary heart disease in Asia","volume":"62","author":"Woo","year":"1997","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinthera.2007.06.020_bib39","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0195-668X(03)00315-4","article-title":"From guidelines to clinical practice: The impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Fox","year":"2003","journal-title":"Eur Heart J"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807001798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807001798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T08:26:25Z","timestamp":1546676785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291807001798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0149291807001798"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2007.06.020","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}